A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment

Summary

The primary purpose of this study is to help answer the following research questions, and not to provide treatment for any condition: * To evaluate how much of the study drug (LY2189265) is in the blood of participants with varying degrees of liver impairment compared to those with normal liver function. * To assess the safety of LY2189265 and any side effects that might be associated with it.

Timeline

Start

2010-11

Primary completion

2011-11

Completion

2011-11

Drugs

Indications